TickerFacts.

Starling Oncology, Inc. (STLN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$29.14M
Year ended 2025-12-31
-$19.28M
Trailing 12 months to 2026-06-30
2020-12-31: -$5.02M2021-12-31: -$42.52M2022-12-31: -$77.54M2023-12-31: -$71.14M2024-12-31: -$53.83M2025-12-31: -$29.14M-$29.14M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$29.14Mn/m2026-03-12, From 2025-01-01
2024-12-31-$53.83Mn/m2026-03-12, From 2024-01-01
2023-12-31-$71.14Mn/m2025-03-26, From 2023-01-01
2022-12-31-$77.54Mn/m2024-03-28, From 2022-01-01
2021-12-31-$42.52Mn/m2023-03-16, From 2021-01-01
2020-12-31-$5.02Mn/a2022-03-11, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Offices & Clinics of Doctors of Medicine), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Starling Oncology, Inc. (STLN)2025-12-31-$29.14Mn/m
SBC Medical Group Holdings Inc (SBC)2025-12-31$70.17M-5.3%
Airsculpt Technologies, Inc. (AIRS)2025-12-31$1.22M-88.2%
Hims & Hers Health, Inc. (HIMS)2025-12-31$160.12M+102.7%
Cardiff Lexington Corp (CDIX)2025-12-31$1.11Mn/m
HealthLynked Corp (HLYK)2025-12-31-$2.01Mn/m

Compare STLN, SBC, AIRS, HIMS side by side · Screen every company in Services-Offices & Clinics of Doctors of Medicine ↗